263 related articles for article (PubMed ID: 14601082)
1. The effect of tumor size and lymph node status on breast carcinoma lethality.
Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B
Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082
[TBL] [Abstract][Full Text] [Related]
2. Predicting the survival of patients with breast carcinoma using tumor size.
Michaelson JS; Silverstein M; Wyatt J; Weber G; Moore R; Halpern E; Kopans DB; Hughes K
Cancer; 2002 Aug; 95(4):713-23. PubMed ID: 12209713
[TBL] [Abstract][Full Text] [Related]
3. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death.
Chen LL; Nolan ME; Silverstein MJ; Mihm MC; Sober AJ; Tanabe KK; Smith BL; Younger J; Michaelson JS
Cancer; 2009 Nov; 115(21):5071-83. PubMed ID: 19658184
[TBL] [Abstract][Full Text] [Related]
4. How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.
Michaelson JS; Chen LL; Silverstein MJ; Mihm MC; Sober AJ; Tanabe KK; Smith BL; Younger J
Cancer; 2009 Nov; 115(21):5095-107. PubMed ID: 19670458
[TBL] [Abstract][Full Text] [Related]
5. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
[TBL] [Abstract][Full Text] [Related]
6. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
7. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
Moore KH; Thaler HT; Tan LK; Borgen PI; Cody HS
Cancer; 2004 Mar; 100(5):929-34. PubMed ID: 14983487
[TBL] [Abstract][Full Text] [Related]
10. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
11. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma.
Foulkes WD; Metcalfe K; Hanna W; Lynch HT; Ghadirian P; Tung N; Olopade O; Weber B; McLennan J; Olivotto IA; Sun P; Chappuis PO; Bégin LR; Brunet JS; Narod SA
Cancer; 2003 Oct; 98(8):1569-77. PubMed ID: 14534871
[TBL] [Abstract][Full Text] [Related]
13. Effect of axillary lymphadenectomy on breast carcinoma survival.
Joslyn SA; Konety BR
Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
16. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
Nassar A; Cohen C; Cotsonis G; Carlson G
Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
[TBL] [Abstract][Full Text] [Related]
17. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
Duraker N; Caynak ZC
Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
[TBL] [Abstract][Full Text] [Related]
19. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
[TBL] [Abstract][Full Text] [Related]
20. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
Singh R; Hellman S; Heimann R
Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
